Stay updated on LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the platform that hosts the study details page. This update reflects backend/frontend improvements rather than changes to the displayed study data.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s UI/version footer was updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a system/template update with no changes to study details.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedPulmonary fibrosis is listed as a condition, and a Genetic and Rare Diseases Information Center resource link has been added.SummaryDifference0.2%

Stay in the know with updates to LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.